Status:
WITHDRAWN
Phototherapy For Treatment Of Raynaud's Phenomenon
Lead Sponsor:
University of Minnesota
Conditions:
Raynaud Disease
Raynaud Phenomenon
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
To determine if blue light therapy can improve the symptoms of Raynaud's phenomenon, and provide parameters for ultimately designing commercial treatment devices, an investigational stationary phototh...
Detailed Description
The purpose of this study is to test the efficacy of blue light phototherapy for the treatment of Raynaud's phenomenon (RP) in human participants. The specific aim is to see if phototherapy treatment ...
Eligibility Criteria
Inclusion
- \- Must have a current diagnosis by a physician of Raynaud's Phenomenon/Syndrome
Exclusion
- Those with active ischemic digital ulcers or gangrene as the cold exposure can be a safety hazard for them.
- Inability of the subject to place their hands into the PTD portal because of physical size or discomfort.
- Inability of the subject to wear protective eyewear.
- Anyone, who in the judgement of any of the investigators, would be unable to safely complete the study procedures.
- Females who are pregnant.
- Adults unable to consent for any reason not explicitly stated herein.
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04898036
Start Date
August 1 2022
End Date
March 1 2023
Last Update
January 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455